Cox Heather
Cox Heather's purchase track record
How the stock did after each of Cox Heather's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 1/13/2025 | ABTC | $38K | -60.0% | +240.1% | +7.4% |
| 12/16/2022 | NRG | $49K | +2.5% | +12.4% | +14.5% |
| 9/8/2022 | AUB | $10K | +10.6% | +10.7% | -2.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
ABTC Joins Broader Bitcoin-Linked Stock Rally. American Bitcoin Corp. shares rose alongside other companies tied to the cryptocurrency market. While the sector saw a general lift, reports note that gains were uneven across different stocks. This move places the stock in a broader context of renewed interest in digital asset equities, though individual performance varied.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
AUB Q3 Earnings Preview: Analysts Expect Growth. Atlantic Union Bankshares is set to report Q3 earnings next week, with Wall Street expecting revenue growth. Recent analyst notes suggest the stock may be undervalued after a significant price run, with one firm upgrading its rating. The company trades at a trailing P/E of 11.1 and offers a 4.06% dividend yield, sitting near its 52-week high of $43.62.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Humana to drop 37 PPOs for 2027 Medicare Advantage plans. Humana announced it will discontinue 37 Preferred Provider Organization (PPO) plans for the 2027 Medicare Advantage enrollment period. The company noted that affected members may qualify for a Medigap open enrollment window without health questions. This structural change impacts the company's product lineup and member retention strategies for the upcoming year.
Transaction History
| NRG | ▲ Buy | Grant | 68 | $0 | 8/3/2026 | View on chart |
| NRG | ▲ Buy | Grant | 1,422 | $0 | 6/1/2026 | View on chart |
| NRG | ▲ Buy | Grant | 79 | — | 5/1/2026 | View on chart |
| NRG | ▲ Buy | Grant | 81 | — | 2/2/2026 | View on chart |
| NRG | ▲ Buy | Grant | 64 | — | 11/3/2025 | View on chart |
| NRG | ▲ Buy | Grant | 66 | $0 | 8/1/2025 | View on chart |
| NRG | ▲ Buy | Grant | 1,149 | $0 | 6/1/2025 | View on chart |
| NRG | ▲ Buy | Grant | 93 | $0 | 5/1/2025 | View on chart |
| NRG | ▲ Buy | Grant | 103 | $0 | 2/3/2025 | View on chart |
| ABTC | ▲ Buy | Open Market | 96,824 | $38K | 1/13/2025 | View on chart |
| NRG | ▲ Buy | Grant | 112 | $0 | 11/1/2024 | View on chart |
| ABTC | ▲ Buy | Grant | 264,080 | $0 | 10/31/2024 | View on chart |
| ABTC | ▲ Buy | Grant | 14,035 | $0 | 8/26/2024 | View on chart |
| NRG | ▲ Buy | Grant | 132 | $0 | 8/1/2024 | View on chart |
| NRG | ▲ Buy | Grant | 2,334 | $0 | 6/1/2024 | View on chart |
| NRG | ▲ Buy | Grant | 150 | $0 | 5/1/2024 | View on chart |
| NRG | ▲ Buy | Grant | 202 | $0 | 2/1/2024 | View on chart |
| NRG | ▲ Buy | Grant | 229 | $0 | 11/1/2023 | View on chart |
| NRG | ▲ Buy | Grant | 264 | $0 | 8/1/2023 | View on chart |
| AUB | ▲ Buy | Grant | 578 | $0 | 7/3/2023 | View on chart |
| NRG | ▲ Buy | Grant | 5,834 | $0 | 6/1/2023 | View on chart |
| NRG | ▲ Buy | Grant | 226 | $0 | 5/1/2023 | View on chart |
| AUB | ▲ Buy | Grant | 428 | $0 | 4/3/2023 | View on chart |
| NRG | ▲ Buy | Grant | 220 | $0 | 2/1/2023 | View on chart |
| AUB | ▲ Buy | Grant | 427 | $0 | 1/3/2023 | View on chart |
| NRG | ▲ Buy | Open Market | 1,571 | $49K | 12/16/2022 | View on chart |
| NRG | ▲ Buy | Grant | 159 | $0 | 11/1/2022 | View on chart |
| AUB | ▲ Buy | Grant | 658 | $0 | 10/3/2022 | View on chart |
| AUB | ▲ Buy | Open Market | 300 | $10K | 9/8/2022 | View on chart |
| NRG | ▲ Buy | Grant | 184 | $0 | 8/1/2022 | View on chart |
| NRG | ▲ Buy | Grant | 4,155 | $0 | 6/1/2022 | View on chart |
| NRG | ▲ Buy | Grant | 147 | $0 | 5/2/2022 | View on chart |
| HUM | ▲ Buy | Option Exercise | 3,967 | $0 | 2/25/2022 | View on chart |
| HUM | ▼ Sell | Tax Withholding | 1,217 | $521K | 2/25/2022 | View on chart |
| NRG | ▲ Buy | Grant | 138 | $0 | 2/1/2022 | View on chart |
| HUM | ▲ Buy | Option Exercise | 328 | $0 | 12/15/2021 | View on chart |
| HUM | ▼ Sell | Tax Withholding | 130 | $60K | 12/15/2021 | View on chart |
| HUM | ▲ Buy | Option Exercise | 406 | $0 | 12/15/2021 | View on chart |
| HUM | ▼ Sell | Tax Withholding | 160 | $74K | 12/15/2021 | View on chart |
| HUM | ▼ Sell | Tax Withholding | 141 | $65K | 12/15/2021 | View on chart |
| HUM | ▲ Buy | Option Exercise | 356 | $0 | 12/15/2021 | View on chart |
| NRG | ▲ Buy | Grant | 122 | $0 | 11/1/2021 | View on chart |
| HUM | ▼ Sell | Tax Withholding | 184 | $74K | 9/1/2021 | View on chart |
| HUM | ▲ Buy | Option Exercise | 752 | $0 | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
NRG Energy faces mixed analyst commentary and market moves
Recent analyst pieces have highlighted NRG’s data‑center outlook and raised questions about its growth prospects. One article noted that the stock appears reasonably priced relative to its current earnings, while another pointed to a larger drop in NRG shares compared with the broader market. A separate report linked a volatility episode at CoreWeave to pressure on NRG’s price. These items keep the stock in focus as investors assess earnings and sector trends.
NRG Energy faces mixed analyst commentary and market moves. Recent analyst pieces have highlighted NRG’s data‑center outlook and raised questions about its growth prospects. One article noted that the stock appears reasonably priced relative to its current earnings, while another pointed to a larger drop in NRG shares compared with the broader market. A separate report linked a volatility episode at CoreWeave to pressure on NRG’s price. These items keep the stock in focus as investors assess earnings and sector trends.